Dashenlin Pharm Grp Co Ltd
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China. It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
Dashenlin Pharm Grp Co Ltd (603233) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.096x
Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) has a cash flow conversion efficiency ratio of 0.096x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥818.72 Million) by net assets (CN¥8.49 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Dashenlin Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Dashenlin Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Dashenlin Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dashenlin Pharm Grp Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Takeuchi Mfg. Co., Ltd.
OTCGREY:TKUGF
|
N/A |
|
Shandong Iron and Steel Co Ltd
SHG:600022
|
0.016x |
|
SUFA Technology Industry Co Ltd CNNC
SHE:000777
|
0.002x |
|
Afry AB
ST:AFRY
|
0.105x |
|
Ningbo Xusheng Auto Technology Co Ltd
SHG:603305
|
0.041x |
|
Grupo Elektra S.A.B. de C.V
MX:ELEKTRA
|
0.204x |
|
Foryou Corp
SHE:002906
|
0.043x |
|
Koninklijke BAM Groep nv
PINK:KBAGF
|
-0.116x |
Annual Cash Flow Conversion Efficiency for Dashenlin Pharm Grp Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Dashenlin Pharm Grp Co Ltd from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥8.14 Billion | CN¥3.11 Billion | 0.382x | -4.60% |
| 2023-12-31 | CN¥7.93 Billion | CN¥3.17 Billion | 0.400x | -26.90% |
| 2022-12-31 | CN¥6.86 Billion | CN¥3.76 Billion | 0.547x | +108.91% |
| 2021-12-31 | CN¥5.94 Billion | CN¥1.55 Billion | 0.262x | -25.28% |
| 2020-12-31 | CN¥5.57 Billion | CN¥1.95 Billion | 0.351x | -11.07% |
| 2019-12-31 | CN¥4.33 Billion | CN¥1.71 Billion | 0.394x | +39.29% |
| 2018-12-31 | CN¥3.09 Billion | CN¥873.64 Million | 0.283x | +23.87% |
| 2017-12-31 | CN¥2.80 Billion | CN¥640.39 Million | 0.228x | -38.12% |
| 2016-12-31 | CN¥1.34 Billion | CN¥495.60 Million | 0.369x | -19.52% |
| 2015-12-31 | CN¥1.02 Billion | CN¥468.59 Million | 0.459x | -41.20% |
| 2014-12-31 | CN¥574.85 Million | CN¥448.58 Million | 0.780x | +59.72% |
| 2013-12-31 | CN¥589.93 Million | CN¥288.22 Million | 0.489x | -35.64% |
| 2012-12-31 | CN¥381.11 Million | CN¥289.31 Million | 0.759x | -- |